Portfolio company
BioVentrix®
United States · £38.3m raised
Raised
£38.3m
Latest stage
Series A
Rounds recorded
1
Backed by
1 investor
Sectors
About
This medical device company develops minimally invasive therapies for cardiothoracic surgeons to treat heart failure by restoring the shape of the left ventricle.
SourceFunding history · 1
Similar companies
Alleviant Medical
This medical device company develops a minimally invasive interatrial shunt therapy without a permanent implant to treat patients suffering from heart failure.
Cardiac Dimensions
This company develops minimally invasive heart implants to treat functional mitral regurgitation in patients with heart failure.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Corvia Medical
This company develops an atrial shunt to treat patients suffering from heart failure with preserved or mildly reduced ejection fraction.
Alleviant
Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.
Cardiac Success Ltd.
This company develops a transcatheter ventricular repair device to treat patients suffering from heart failure with reduced ejection fraction.
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
CardiAQ Valve Technologies (CVT)
This company develops transcatheter mitral valve replacement systems to treat heart disease patients through minimally invasive procedures.
